Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15
Published November 3, 2021 · Recall initiated: October 12, 2021
Summary
FDA records drug Class III recall D-0068-2022, published November 3, 2021 and initiated October 12, 2021. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 22,752 blister packs; Lot: Lot #: AC14635, Exp. Date 12/2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Moisture Limits
What to do
Voluntary: Firm initiated · Letter
Get an email if LORATADINE AND PSEUDOEPHEDRINE SULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LORATADINE AND PSEUDOEPHEDRINE SULFATE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Nationwide within the United States
- Lot
- Lot #: AC14635, Exp. Date 12/2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPROGESTERONE 100MG/ML MDV OIL INJECTION, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDAAllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10/240mg), 15-countNovember 3, 2021
- FDAMIT/B12 25/50/50MG/ML 1MG/ML MDV, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDAPainAway II (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets , 2 tablets/pk, packaged in 12,000November 3, 2021
- FDAMIC/B12A/B6 15/50/100 5MG/50MG/ML MDV, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDANon-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg ,April 30, 2014
Questions about this recall
Was Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15 recalled?
Yes. FDA published recall D-0068-2022 on November 3, 2021. Reported hazard: Failed Moisture Limits
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LORATADINE AND PSEUDOEPHEDRINE SULFATE.